Integer Holdings Corporation
ITGR
Classement en actions
#3831
Integer Holdings Corporation functions as a global leader in outsourced medical... Integer Holdings Corporation functions as a global leader in outsourced medical device manufacturing, maintaining operations across the United States, Puerto Rico, Costa Rica, and other international regions. The company organizes its business into two primary divisions: Medical and Non-Medical. Within its Medical segment, Integer delivers a broad array of devices and components essential for numerous advanced medical procedures. These solutions cater to areas such as interventional cardiology, structural heart conditions, heart failure management, peripheral and neurovascular interventions, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology. Their extensive product portfolio includes cardiac rhythm management devices like implantable pacemakers, defibrillators, cardiac monitors, leads, and heart failure therapies. They also produce neuromodulation devices, such as implantable spinal cord stimulators, alongside critical components like non-rechargeable batteries, feedthroughs, device enclosures, precision-machined parts, and lead sub-assemblies. Furthermore, Integer provides rechargeable battery systems and chargers. A comprehensive range of surgical instruments and components is also offered for arthroscopic, laparoscopic, and general surgery, encompassing items like harmonic scalpels, various blades and shavers, radio frequency and biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment parts, and phacoemulsification needles. Orthopedic offerings comprise specialized instruments for hip, knee, and spine surgeries, including reamers and chisels, among other general medical technologies. The Non-Medical segment concentrates on developing customized battery power and management systems, along with specialized battery solutions, designed for the energy, military, and environmental sectors. Integer primarily collaborates with multinational original equipment manufacturers (OEMs) and their affiliated subsidiaries, supporting their requirements across diverse markets, including cardiac, neuromodulation, orthopedics, vascular, advanced surgical, and portable medical applications. Established in 1970, Integer Holdings Corporation is headquartered in Plano, Texas.
Prix de l'action
$126.75
Dernière synchronisation: 2026-10-19
Capitalisation boursière
$4.31B
Changement (1 jour)
0.04%
Changement (1 an)
18.05%
Pays
US
Échange Integer Holdings Corporation (ITGR)
Catégorie
Healthcare
Bénéfices pour Integer Holdings Corporation (ITGR)
Bénéfices en Jul 2026 TTM : $136.44M
Selon les derniers rapports financiers de Integer Holdings Corporation, les bénéfices actuels de l'entreprise sont de $136.44M. En 2023, l'entreprise a réalisé un bénéfice de $105.38M, une augmentation par rapport à celui de 2022 qui était de $68.68M. Les bénéfices affichés sur cette page correspondent aux bénéfices avant intérêts et impôts, appelés aussi EBIT.
Historique des bénéfices pour Integer Holdings Corporation de 2000 à 2026
Bénéfices à la fin de chaque année
| Année | Bénéfices | Changez |
|---|---|---|
| 2026 (TTM) | $136.44M | -7.54% |
| 2024 | $147.56M | 40.03% |
| 2023 | $105.38M | 53.45% |
| 2022 | $68.68M | -32.05% |
| 2021 | $101.06M | 17.23% |
| 2020 | $86.21M | -18.05% |
| 2019 | $105.19M | 72.12% |
| 2018 | $61.12M | 24.07% |
| 2017 | $49.26M | 74.89% |
| 2016 | $28.17M | -279.39% |
| 2015 | $-15.70M | -120.50% |
| 2014 | $76.58M | 56.80% |
| 2013 | $48.84M | 625.68% |
| 2012 | $6.73M | -86.09% |
| 2011 | $48.39M | -1.89% |
| 2010 | $49.33M | -371.36% |
| 2009 | $-18.18M | -166.58% |
| 2008 | $27.30M | -4.83% |
| 2007 | $28.69M | 21.90% |
| 2006 | $23.53M | 52.19% |
| 2005 | $15.46M | -34.84% |
| 2004 | $23.73M | -28.77% |
| 2003 | $33.32M | 58.91% |
| 2002 | $20.97M | 13.14% |
| 2001 | $18.53M | 1,036.11% |
| 2000 | $1.63M | 0.00% |
Bénéfices des entreprises similaires ou concurrentes
| Entreprise | Bénéfices | Différence de bénéfices | Pays |
|---|---|---|---|
| $7.51B | 5,404.94% |
US
|
|
| $5.56B | 3,977.22% |
IE
|
|
| $5.15B | 3,673.06% |
US
|
|
| $3.86B | 2,729.79% |
US
|
|
| - | - |
DE
|
